Atlantic Bone Screen

Atlantic Bone Screen Company, a biotechnology company, engages in developing a preclinical platform that allows the identification and

Atlantic Bone Screen Company, a biotechnology company, engages in developing a preclinical platform that allows the identification and evaluation of therapeutic drugs in osteoarticular pathologies to the pharmaceutical, biotechnological, and chemical industries. It offers in vitro services, such as various biological assays, including chondrocytes, osteoblasts, osteoclasts, and tumor cell lines based on osteoarticular cell models from human and animal origin; and in vivo services, which include various experimental models that reproduce the processes of bone resorption, as well as models of human bone pathologies. The company was founded in 2005 and is based in Nantes, France.